Balyasny Asset Management »

Nautilus Biotechnology shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $25k 13k 1.87
2022-03-31 $127k 29k 4.35

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr St Str Finl Etf Call Option (XLF)
Meta Platforms Cl A Call Option (META)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Microsoft Corporation Call Option (MSFT)
Tesla Motors Call Option (TSLA)

View all positions for Balyasny Asset Management

Top funds holding Nautilus Biotechnology

Perceptive Advisors
AH Capital Management
Cercano Management
BlackRock
Vanguard Capital Management
Comprehensive Financial Management
Citadel Advisors
Geode Capital Management
Acadian Asset Management
Hartland & Co
Susquehanna International
_Sentinel Trust Company, LBA______________
Barclays
Renaissance Technologies
Jpmorgan Chase & Co

View all funds holding Nautilus Biotechnology